NOV
45
2
HSIC
42
2
WMT
68
-2
EA
41
3
DIS
70
2
MCD
52
3
COF
48
3
HD
43
8
CMI
49
2
ADT
12
2
ALL
37
3
THC
52
9
SBUX
29
-2
ZION
49
9
NKE
36
2
TAP
57
6
ADBE
50
3
AEE
51
3
WM
53
2
F
38
4
NOV
45
2
HSIC
42
2
WMT
68
-2
EA
41
3
DIS
70
2
MCD
52
3
COF
48
3
HD
43
8
CMI
49
2
ADT
12
2
ALL
37
3
THC
52
9
SBUX
29
-2
ZION
49
9
NKE
36
2
TAP
57
6
ADBE
50
3
AEE
51
3
WM
53
2
F
38
4
Financhill
Back

Krystal Biotech Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
25

KRYS
Krystal Biotech

Last Price:
$165.06
Seasonality Move:
4.67%
Sell
27

ALNY
Alnylam Pharmaceuticals

Last Price:
$245.56
Seasonality Move:
2.78%
Sell
25
Krystal Biotech (KRYS) is a Sell

Is Krystal Biotech a Buy, Sell or Hold?

  • The current Krystal Biotech [KRYS] share price is $164.75. The Score for KRYS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KRYS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $245.50. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KRYS Stock Price Chart

What is Krystal Biotech's stock price today?

  • The Krystal Biotech share price today is $164.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRYS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $245.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

KRYS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.61 Sell
Relative Strength Index (14 RSI): 40.26 Sell
Chaikin Money Flow: 564694 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (168.49 - 192.07) Sell
Bollinger Bands (100): (173.5 - 194.06) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.01 Sell
Relative Strength Index (14 RSI): 43.61 Sell
Chaikin Money Flow: 935904 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (240.56 - 254.54) Sell
Bollinger Bands (100): (251.01 - 281.19) Sell

KRYS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 167.88 Sell
20-day SMA: 181.12 Sell
50-day SMA: 179.74 Sell
200-day SMA: 179.48 Sell
8-day EMA: 167.77 Sell
20-day EMA: 175.22 Sell
50-day EMA: 179.61 Sell
200-day EMA: 172.3 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 244.71 Buy
20-day SMA: 249.56 Sell
50-day SMA: 264.07 Sell
200-day SMA: 220.46 Buy
8-day EMA: 244.75 Buy
20-day EMA: 249.26 Sell
50-day EMA: 256.57 Sell
200-day EMA: 234.24 Buy

Krystal Biotech Earnings Growth & KRYS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.65 per share, and an increase next year of $1.53 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.71 per share.

Krystal Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):